rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Thomas P. Looney

Director

Company insider

Files Form 4 as: Director, Tilray Brands.

In numbers

Trades disclosed
34
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
30 Apr 2021
Last trade
30 Jul 2026
Last filed
30 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
TLRY Tilray BrandsDirector · Pharmaceuticals · last 30 Jul 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
30 Jul 2026filed 30 Jul 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—62,657 at $0.00filing
30 Jul 2026filed 30 Jul 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—62,657 at $0.00filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M—43,104 at $0.00filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—43,104 at $0.00filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—43,104 at $0.00filing
29 Jul 2026filed 30 Jul 2026TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M—43,104 at $0.00filing
30 Jul 2025filed 31 Jul 2025TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—124,378 at $0.00filing
30 Jul 2025filed 31 Jul 2025TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M$76K124,378 at $0.61filing
29 Jul 2025filed 31 Jul 2025TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—431,034 at $0.00filing
30 Jul 2024filed 30 Jul 2024TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—124,378 at $0.00filing
26 Jul 2024filed 30 Jul 2024TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—129,534 at $0.00filing
26 Jul 2024filed 30 Jul 2024TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M$237K129,534 at $1.83filing
21 Jun 2024filed 24 Jun 2024TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—3,858 at $0.00filing
21 Jun 2024filed 24 Jun 2024TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M$6,4043,858 at $1.66filing
26 Jul 2023filed 27 Jul 2023TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code D—70,621 at $0.00filing
26 Jul 2023filed 27 Jul 2023TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—129,534 at $0.00filing
26 Jul 2023filed 27 Jul 2023TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M$136K70,621 at $1.93filing
21 Jun 2023filed 23 Jun 2023TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code M—3,858 at $0.00filing
21 Jun 2023filed 23 Jun 2023TLRY Tilray BrandsPharmaceuticalsSEC FORM 4 Code M$6,0963,858 at $1.58filing
26 Jul 2022filed 27 Jul 2022TLRY Tilray Brandsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—70,621 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Denise M. FaltischekChief Strategy Officer · Chief Strategy Officer at Tilray Brands, filing Form 4 there in the last year
Carl A. MertonChief Financial Officer · Chief Financial Officer at Tilray Brands, filing Form 4 there in the last year
Mitchell GendelGlobal General Counsel · Global General Counsel at Tilray Brands, filing Form 4 there in the last year
Irwin D. SimonPresident and CEO · President and CEO at Tilray Brands, filing Form 4 there in the last year
Johann Michael HerhaltDirector · Director at Tilray Brands, filing Form 4 there in the last year